Torrent Pharmaceuticals Limited
TORNTPHARM
주식 순위
#1201
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
주가
$50.31
마지막 동기화: 2026-10-19
시가총액
$19.14B
변동 (1일)
-0.14%
변동 (1년)
23.83%
국가
IN
거래 Torrent Pharmaceuticals Limited (TORNTPHARM)
카테고리
Healthcare
Torrent Pharmaceuticals Limited (TORNTPHARM)의 발행 주식 수
June 2026 기준 발행 주식 수: 338.45M
Torrent Pharmaceuticals Limited의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 338.45M입니다. March 2024 말 기준 회사는 338.45M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Torrent Pharmaceuticals Limited (TORNTPHARM)의 발행 주식 수 기록 (2005 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 338.45M | 0.01% |
| 2025 | 338.41M | -0.01% |
| 2024 | 338.45M | 0.00% |
| 2023 | 338.45M | 0.00% |
| 2022 | 338.45M | 0.00% |
| 2021 | 338.45M | 0.00% |
| 2020 | 338.45M | 0.00% |
| 2019 | 338.45M | 0.00% |
| 2018 | 338.45M | 0.00% |
| 2017 | 338.45M | 0.00% |
| 2016 | 338.45M | 0.00% |
| 2015 | 338.45M | 0.00% |
| 2014 | 338.45M | 0.00% |
| 2013 | 338.45M | 0.00% |
| 2012 | 338.45M | 0.00% |
| 2011 | 338.44M | 0.00% |
| 2010 | 338.44M | 0.00% |
| 2009 | 338.44M | 0.00% |
| 2008 | 338.44M | 0.00% |
| 2007 | 338.44M | 0.00% |
| 2006 | 338.44M | 0.00% |
| 2005 | 338.44M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 608.93% |
IN
|
